Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00TYR
|
|||
| Former ID |
DIB011563
|
|||
| Drug Name |
Anti-tubulin agents
|
|||
| Synonyms |
JAC program, Jeil; JAC-106; JI-1106; JL-1106; Anti-tubulin agents (multidrug-resistant cancer); Antitubulin agents (MDR cancer), Jeil/Korea Research Institute of Bioscience and Biotechnology; Anti-tubulin agents (multidrug-resistant cancer), Jeil/KRIBB
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Jeil Pharmaceutical Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.